Galmed Announces A Delay Of At Least Six Months In The Initiation Of Its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Galmed Announces A Delay Of At Least Six Months In The Initiation Of Its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Galmed宣布其原发性硬化性胆管炎（PSC）2a期研究的启动延迟至少六个月
Galmed Announces A Delay Of At Least Six Months In The Initiation Of Its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Galmed宣布其原发性硬化性胆管炎（PSC）2a期研究的启动延迟至少六个月
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。